Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Onyx, W-L collaborate on antiinflammatory and immunomodulating agents

Aug. 18, 1997

Patent allowances granted to Genelabs for DNA-binding technology

Aug. 14, 1997

Oxis licenses PEG technology to Enzon

Aug. 14, 1997

Secreted proteins strategic alliance between Genset and Genetics Institute

Aug. 13, 1997

Lilly and Acacia Biosciences sign research collaboration

Aug. 12, 1997

Lidak licenses ADIFAB technology to Aurora Biosciences

Aug. 12, 1997

Proteome project collaboration announced

Aug. 12, 1997

Galanin receptor research collaboration between Synaptic and Warner-Lambert

Aug. 11, 1997

Aquila issued patent covering potent drug delivery agents

Aug. 8, 1997

Transkaryotic Therapies allowed European patent for gene therapy technology

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...